期刊文献+

心外膜脂肪脂联素水平与冠状动脉病变程度的关系 被引量:9

Relation between epicardial adiponectin level and coronary artery lesion
下载PDF
导出
摘要 目的:探讨冠心病患者心外膜脂肪脂联素水平与冠状动脉病变程度的关系。方法选择冠心病及心脏瓣膜病手术患者168例,分为冠心病组86例和瓣膜病组82例,同时冠心病组按冠状动脉病变程度积分分为<30分23例、30~90分35例、>90分28例,分别采集患者的心外膜脂肪及血清标本,采用酶联免疫法及RT‐PCR分别测定血清脂联素及脂肪脂联素mRNA的表达。结果冠心病组血清脂联素低于瓣膜病组[(9.1±3.1)mg/L vs (13.5 ± 3.9)mg/L ,P<0.05],冠心病组积分<30分、30~90分、>90分患者血清脂联素分别为(12.3±4.8)mg/L、(9.1±4.5)mg/L和(7.2±5.1)mg/L ,差异有统计学意义(P<0.05)。与瓣膜病组比较,冠心病组心外膜脂肪脂联素mRNA表达降低(P<0.05)。结论老年冠心病患者随冠状动脉病变程度加重,血清及心外膜脂肪脂联素水平下降。 Obejective To study the relation between epicardial adiponectin level and coronary ar‐tery lesion in CHD patients .Methods One hundred and sixty eight CHD and valvular disease (VD) patients admitted to our hospital were divided into CHD group (n=86) and VD group(n=82) .Patients in CHD group were further divided into 〈30 lesion score group (n=23) ,30-90 le‐sion score group (n=35)and 90 lesion score group (n=28) .Epicardial adipose tissue and serum samples were taken from the patients .Their serum adiponectin level was measured and adipokine mRNA expression was detected by ELISA and RT‐PCR ,respectively .Results The serum adi‐ponectin level was significantly lower in CHD group than in VD group (9 .1 ± 3 .1 mg/L vs 13 .5 ± 3 .9 mg/L ,P〈0 .05) ,〈30 lesion score group ,30 -90 lesion score group and >90 lesion score group (12 .3 ± 4 .8mg/L ,9 .1 ± 4 .5 mg/L ,7 .2 ± 5 .1 mg/L ,P〈 0 .05) .The adiponectin mRNA expression level was significantly lower in CHD group than in VD group (P〈0 .05) .Conclusion The serum epicardial adiponectin level decreases with the severity of coronary lesions in elderly CHD patients .
出处 《中华老年心脑血管病杂志》 CAS 2015年第3期270-272,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 河南省教育厅自然科学基金(2011A320009)
关键词 脂联素 冠心病 心包 心脏瓣膜疾病 RNA 信使 adiponectin coronary disease pericardium heart valve diseases RNA,messenger
  • 相关文献

参考文献12

二级参考文献189

  • 1刘军,陈影,刘芳,姚庆姑,许火根,澎名淑,郭瑜琳,陈钦达.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性研究[J].中华内分泌代谢杂志,2004,20(3):215-216. 被引量:30
  • 2刘岩,邹大进,李慧,陈月,丁继军,郑兴,郭鹏飞.低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):5-8. 被引量:111
  • 3高小亚,戈敏娟,马向华.单纯性肥胖患者血清瘦素、抵抗素和脂联素水平的研究[J].医学研究生学报,2006,19(6):544-547. 被引量:25
  • 4Iacobellis G, Corradi D, Sharma AM, et al. Epicardial adipose tissue: anatomic, biomoleeular and clinical relationships with the heart [J]. Cardiovascular Medicine, 2005, 2(10):536-543.
  • 5Silaghi A, Piercecchi-Marti MD, Grino M, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy[J]. Obesity, 2008, 16(11): 2424-2430.
  • 6Yudkin J S, et al. Inflammation, obesity and the metabolic syndrome [J]. Horm metab Res, 2007, 39:707-709.
  • 7I Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponeetin expression in human epicardial adipose tissue is lower in patients with coronary artery disease[J]. Cytokine, 2005, 29:251 -255.
  • 8Cheng KH, Chu CS, Lee KT, et al. Adipoeytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease[J]. International Journal of Obesity, 2008(32): 268-274.
  • 9Spiroglou S, Kostopoulos C, Varakis J, et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis[J]. J Atheroscler Thromb, 2010, 17:115-130.
  • 10Wang P, Xu TY, Guan YF, et al. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide [J]. Cardiovasc Res, 2009, 81 (2): 370-380.

共引文献188

同被引文献82

  • 1陈新忠,焦周阳,汪雷,孙宗全,魏玉涛,王现国,夏东升.Roles of Human Epicardial Adipose Tissue in Coronary Artery Atherosclerosis[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(5):589-593. 被引量:2
  • 2李浙成,童跃峰,胡智星,黄金莲,徐永远,吴青,应显星,胡江飚.心外膜脂肪组织厚度与代谢综合征的关系[J].中华内分泌代谢杂志,2007,23(2):164-165. 被引量:7
  • 3Sen D,González-Mayda M,Brasington RD Jr.Cardiovascular disease in rheumatoid arthritis.Rheum Dis Clin North Am,2014,40:27-49.
  • 4Adya R,Tan BK,Randeva HS.Differential effects of leptin and adiponectin in endothelial angiogenesis.J Diabetes Res,2015,2015:648239.
  • 5Dessein PH,Tsang L,Solomon A,et al.Adiponectin and atherosclerosis in rheumatoid arthritis.Mediators Inflamm,2014,2014:358949.
  • 6El-Hini SH,Mohamed FI,Hassan AA,et al.Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients.Rheumatol Int,2013,33:2283-2289.
  • 7Arnett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism Association 1987revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,1988,31:315-324.
  • 8Liao KP,Solomon DH.Traditional cardiovascular risk factors,inflammation and cardiovascular risk in rheumatoid arthritis.Rheumatology(Oxford),2013,52:45-52.
  • 9Oranskiy SP,Yeliseyeva LN,Tsanaeva AV,et al.Body composition and serum levels of adiponectin,vascular endothelial growth factor,and interleukin-6in patients with rheumatoid arthritis.Croat Med J,2012,53:350-356.
  • 10Ohashi K,Parker JL,Ouchi N,et al.Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype.J Biol Chem,2010,285:6153-6160.

引证文献9

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部